Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: A4H814
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 122 | 124 | PF00675 | 0.464 |
CLV_NRD_NRD_1 | 76 | 78 | PF00675 | 0.687 |
CLV_PCSK_KEX2_1 | 122 | 124 | PF00082 | 0.466 |
CLV_PCSK_PC7_1 | 118 | 124 | PF00082 | 0.487 |
CLV_PCSK_SKI1_1 | 123 | 127 | PF00082 | 0.452 |
CLV_PCSK_SKI1_1 | 78 | 82 | PF00082 | 0.612 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.607 |
DOC_CKS1_1 | 19 | 24 | PF01111 | 0.617 |
DOC_MAPK_DCC_7 | 52 | 62 | PF00069 | 0.562 |
DOC_MAPK_RevD_3 | 64 | 78 | PF00069 | 0.447 |
DOC_PP2B_PxIxI_1 | 57 | 63 | PF00149 | 0.441 |
DOC_WW_Pin1_4 | 18 | 23 | PF00397 | 0.620 |
DOC_WW_Pin1_4 | 28 | 33 | PF00397 | 0.762 |
DOC_WW_Pin1_4 | 82 | 87 | PF00397 | 0.362 |
LIG_14-3-3_CanoR_1 | 122 | 131 | PF00244 | 0.682 |
LIG_14-3-3_CanoR_1 | 2 | 9 | PF00244 | 0.611 |
LIG_14-3-3_CanoR_1 | 77 | 87 | PF00244 | 0.460 |
LIG_FHA_1 | 124 | 130 | PF00498 | 0.682 |
LIG_FHA_1 | 79 | 85 | PF00498 | 0.462 |
LIG_GBD_Chelix_1 | 61 | 69 | PF00786 | 0.419 |
LIG_LIR_Gen_1 | 67 | 75 | PF02991 | 0.480 |
LIG_LIR_Nem_3 | 67 | 73 | PF02991 | 0.410 |
LIG_REV1ctd_RIR_1 | 93 | 103 | PF16727 | 0.349 |
LIG_SH2_CRK | 70 | 74 | PF00017 | 0.462 |
LIG_SH2_STAT5 | 46 | 49 | PF00017 | 0.615 |
LIG_SH3_3 | 29 | 35 | PF00018 | 0.749 |
LIG_SH3_3 | 6 | 12 | PF00018 | 0.685 |
LIG_SUMO_SIM_par_1 | 70 | 76 | PF11976 | 0.227 |
LIG_SxIP_EBH_1 | 52 | 63 | PF03271 | 0.558 |
LIG_TYR_ITIM | 68 | 73 | PF00017 | 0.227 |
MOD_CK1_1 | 124 | 130 | PF00069 | 0.663 |
MOD_GlcNHglycan | 15 | 18 | PF01048 | 0.418 |
MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.557 |
MOD_GSK3_1 | 78 | 85 | PF00069 | 0.451 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.725 |
MOD_NEK2_1 | 64 | 69 | PF00069 | 0.438 |
MOD_NEK2_1 | 80 | 85 | PF00069 | 0.425 |
MOD_PIKK_1 | 38 | 44 | PF00454 | 0.723 |
MOD_PIKK_1 | 52 | 58 | PF00454 | 0.507 |
MOD_PKA_2 | 1 | 7 | PF00069 | 0.711 |
MOD_PKA_2 | 121 | 127 | PF00069 | 0.685 |
MOD_Plk_1 | 38 | 44 | PF00069 | 0.722 |
MOD_Plk_4 | 46 | 52 | PF00069 | 0.629 |
MOD_Plk_4 | 64 | 70 | PF00069 | 0.250 |
MOD_ProDKin_1 | 18 | 24 | PF00069 | 0.619 |
MOD_ProDKin_1 | 28 | 34 | PF00069 | 0.756 |
MOD_ProDKin_1 | 82 | 88 | PF00069 | 0.362 |
TRG_ENDOCYTIC_2 | 70 | 73 | PF00928 | 0.398 |
TRG_Pf-PMV_PEXEL_1 | 99 | 103 | PF00026 | 0.464 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PAK1 | Leptomonas seymouri | 66% | 100% |
A0A0S4JX73 | Bodo saltans | 37% | 100% |
A0A1X0NVE4 | Trypanosomatidae | 45% | 100% |
A0A3R7RL81 | Trypanosoma rangeli | 42% | 85% |
A0A3S7WTD5 | Leishmania donovani | 80% | 95% |
A4HWE4 | Leishmania infantum | 81% | 95% |
C9ZNY5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 100% |
E9AQ44 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 77% | 95% |
Q4QFD8 | Leishmania major | 78% | 100% |